Mass Spectra of Designer Drugs 2013 Upgrade

Erscheinungsjahr 2013
ISBN: 978-3-527-33401-8
Verlag: WILEY-VCH

Sonstiges, Englisch, CD-ROM with Booklet

Compounds classified as Designer Drugs have been synthesized since the early 1980s. This is not a precise scientific term and should only be applied to those drugs that are synthesized from common chemicals and skillfully marketed under attractive, often exotic names. The last decade has seen a proliferation of such substances, such that keeping abreast of this huge number of new drugs is a difficult task for forensic chemists and toxicologists.
The Designer Drugs 2013 cover the entire range of designer drugs up to December 2012.
Carefully compiled by the mass spectral experts at the Regional Departments of Criminal Investigation in Kiel, Hamburg, and Wiesbaden, Germany, this database includes:

- xxx chemical compounds
- yyy mass spectra, about zzz% more than the 2012 edition
- Chemical structures
- Chemical warfare agents, added due to the recent interest in homeland security
- Data taken from both legal and underground literature, providing the most comprehensive picture of these compounds
- Average peaks per spectrum: 160
- Average Quality Index: 932
- Experimental Kovats indices: 4957
- Calculated Kovats indices

Compound classes:

amphetamines: 904
methylenedioxyphenethylamines: 514
phenethylamines: 1032
tryptamines: 243
piperazines: 356
opiates: 146
fentanyles: 240
cathinones: 98
phencyclidines: 14
barbiturates: 56
arylpropan-2-amines: 102
arylbutan-2-amines: 386
1-aryl-2-nitro-ethenes: 41
1-aryl-2-nitroprop-1-enes: 64
1-aryl-2-nitrobut-1-ene: 45
benzaldehydes: 144
benzodiazepines: 218
designer drug isomers: 375
derivatives: 3258
metabolites incl. derivatives: 2366
chemical warfare agents: 67
designer drug precursors: 588
pharmaceutical drugs incl. metabolites: 3132
pesticides: 166
explosives: 24
controlled compounds: 1043

Available Database Formats: ACD; Agilent Chemstation; NIST MSSEARCH; Finnigan GCQ, SSQ, TSQ, ICIS, INCOS, Iontrap, ITS40, Magnum; INCOS; PE Turbomass; Shimadzu QP-5000; Thermo Galactic SpectralID; Varian Saturn;VG Labbase, Masslab; Waters Masslynx; Xcalibur

Autoren/Hrsg.

Rösner, Peter

Fachgebiete

• Naturwissenschaften Chemie Chemie Allgemein Pharmazeutische Chemie, Medizinische Chemie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Naturwissenschaften Chemie Analytische Chemie Massenspektrometrie, Spektroskopie, Spektrochemie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Pharmazeutische Technologie

Über Autor(innen)

Peter Rösner (born 1944) studied Chemistry at the University of Kiel (Germany). In 1981 he became head of the toxicology department at the state agency of criminal investigation (Landeskriminalamt) in Kiel, where he focuses on drug identification and structure elucidation with GC/MS methods. Since 1992 he has also been a lecturer for mass spectrometry at the University of Kiel. In 2005, Dr. Rösner received the Jean-Servais-Stas Award from the Society of Toxicological and Forensic Chemistry in honor of his outstanding work in forensic sciences.
Thomas Junge (born 1959) studied Technical Chemistry at the University of Applied Science of Lübeck (Germany). Since 1985 he has been a specialist for daughter ion mass spectroscopy in the toxicology department at the Landeskriminalamt in Kiel. His contribution was essential in building a mass spectral daughter ion data base for the structure eludication of new designer drugs.
Folker Westphal (born 1965) studied Chemistry at the Universities of Hannover and Kiel (Germany), and also holds a degree as Special Chemist for Toxicology from the University of Leipzig. From 1999 to 2004 he worked at the Institute of Legal Medicine in Kiel as forensic scientist. Since 2004 he is leader of the section "Analysis of Drugs of Abuse and Forensic Toxicology" at the Landeskriminalamt in Kiel.
Giselher Fritschi (born 1944) studied Chemistry at the Universities of Mainz and Karlsruhe (Germany). After a postdoc year at the University of Marburg he joined the Bundesgesundheitsamt (Federal Health Office) in Frankfurt. In 1978 he changed to the Landeskriminalamt in Wiesbaden as forensic expert for toxicological analysis, focusing on the structure elucidation of new designer drugs.